One-year clinical outcomes of patients with versus without acute coronary syndrome with 3-month duration of dual antiplatelet therapy after everolimus-eluting stent implantation

類似資料

• One-year outcome of a prospective trial stopping dual antiplatelet therapy at 3 months after everolimus-eluting cobalt-chromium stent implantation: ShortT and OPtimal duration of Dual AntiPlatelet Therapy after everolimus-eluting cobalt-chromium stent (STOPDAPT) trial
  著者:: Natsuaki, Masahiro, 等
  出版事項: (2015)
• Ischemic and Bleeding Risk After Percutaneous Coronary Intervention in Patients With Prior Ischemic and Hemorrhagic Stroke
  著者:: Natsuaki, Masahiro, 等
  出版事項: (2019)
• Prediction of Thrombotic and Bleeding Events After Percutaneous Coronary Intervention: CREDO‐Kyoto Thrombotic and Bleeding Risk Scores
  著者:: Natsuaki, Masahiro, 等
  出版事項: (2018)
• Impact of Angiographic Residual Stenosis on Clinical Outcomes After New‐Generation Drug‐Eluting Stents Implantation: Insights From a Pooled Analysis of the RESET and NEXT Trials
  著者:: Watanabe, Hiroki, 等
  出版事項: (2018)
• Prognostic Impact of Baseline Hemoglobin Levels on Long‐Term Thrombotic and Bleeding Events After Percutaneous Coronary Interventions
  著者:: Nagao, Kazuya, 等
  出版事項: (2019)